L-Glutamine

L-Glutamine is the most abundant free amino acid in the human body and the one most associated with the gut. Under normal conditions it is "non-essential" — your body makes plenty of it, mainly in skeletal muscle. What makes it interesting for gut health is that it is the preferred metabolic fuel of the enterocytes, the rapidly-dividing cells that form the lining (epithelium) of the small intestine. These cells turn over every few days and burn through glutamine to do it, which is why the gut is one of the body's biggest glutamine consumers.

The key concept for a buyer to understand is "conditionally essential". During major physiological stress — severe burns, trauma, sepsis, surgery, prolonged critical illness — the body's demand for glutamine outstrips what it can produce, blood levels fall, and the gut lining can be among the first tissues to suffer (villus atrophy, weakened barrier). In those clinical settings, supplementing glutamine has measurable effects. That is a very different situation from a generally healthy person with bloating or food sensitivities, and conflating the two is the central marketing problem in this category.

As a supplement, L-glutamine is sold as a cheap, near-tasteless white powder (also capsules) — usually 5 g per scoop, often marketed for "gut repair", "leaky gut", and as a muscle-recovery aid. The form is not the issue here (unlike curcumin, plain L-glutamine is well absorbed); the honest question is whether the dose and your situation match the evidence. The strongest human data sit at the clinical end, with one genuinely impressive trial in diarrhoea-predominant IBS bridging toward everyday use.

Glutamine's gut role rests on two linked mechanisms. First, fuel: enterocytes oxidise glutamine as their main energy source, so an adequate supply supports the constant renewal of the intestinal lining (Wang 2015, PMID 24965526). Second, barrier integrity: glutamine availability influences the tight junctions — the protein "zippers" (occludin, claudins, ZO-1) between adjacent gut cells that decide how leaky the barrier is. In cell and animal models, glutamine deprivation loosens these junctions and raises permeability, while restoring glutamine tightens them. This is the mechanistic spine of the whole "leaky gut" rationale: a more permeable barrier is thought to let bacterial fragments (endotoxin) cross into circulation and drive low-grade inflammation, and glutamine is positioned as the nutrient that helps keep the barrier sealed.

The most persuasive human evidence is the IBS-D trial by Zhou and colleagues (Zhou 2019, PMID 30108163, Gut). They took patients who developed diarrhoea-predominant IBS *after* an enteric infection — and specifically those with documented increased intestinal permeability — and gave 5 g of glutamine three times daily for eight weeks. The result was dramatic: a ≥50-point drop in IBS symptom severity in about 80% of the glutamine group versus 6% on placebo, alongside reduced stool frequency and normalised permeability. In the critical-illness setting, an ICU RCT found early enteral glutamine cut plasma zonulin (a permeability marker) by roughly 40% versus placebo (Shariatpanahi 2019, PMID 31485104).

The honest counterweight is twofold. The classic skeptical review (Burrin 2006, PMID 17024034) argued that glutamine is not actually a *uniquely* essential small-intestinal fuel — glutamate and aspartate matter too — and that supplement benefits, where real, may not come from the gut-fuel story. And a 2024 meta-analysis across adult trials (Abbasi 2024, PMID 39397201) found no significant overall effect of glutamine on intestinal permeability, with benefit appearing only in a subgroup using high doses (>30 g/day) over a short period. So the picture is: a real mechanism, a striking effect in a specific high-permeability IBS-D population, clinical value under extreme stress — and no good evidence that a few grams a day reseals the gut of an otherwise-healthy person.